Year archive

Pharming Group N.V. — 2009 filings

All 40 regulatory filings released by Pharming Group N.V. (PHARM) in 2009, sourced directly from the official regulator.

40 Filings

2009 Period

2009 filings (40)

Filing	Released	Lang
Pharming completes pre-BLA meeting with US FDA for Rhucin submission Regulatory Filings	2009-12-09	English
PHARMING TO PRESENT AT BIO-EUROPE 2009 Regulatory Filings	2009-10-27	English
Pharming recombinant human C1 inhibitor: results in pre-clinical ischaemic reperfusion model confirm potential for new indications Regulatory Filings	2009-10-23	English
Pharming announces third quarter 2009 results Interim / Quarterly Report 9M 2009	2009-10-16	English
Interim / Quarterly Report 2009 Interim / Quarterly Report 9M 2009	2009-10-16	English
Pharming confirms successful closing of offer on convertible bonds Capital/Financing Update	2009-10-14	English
Pharming finalizes conversion of 70% of outstanding bonds Share Issue/Capital Change	2009-10-08	English
Pharming secures additional € 10 million financing from Yorkville Advisors Capital/Financing Update	2009-10-05	English
PHARMING PROVIDES UPDATE ON OUTSTANDING SHARES Share Issue/Capital Change	2009-10-01	English
Pharming receives commitment for conversion of 70% of outstanding bonds Capital/Financing Update	2009-09-30	English
PHARMING RECEIVES COMMITMENT FOR CONVERSION OF 70% OF OUTSTANDING BONDS Capital/Financing Update	2009-09-30	English
PHARMING RECEIVES COMMITMENT FOR CONVERSION OF 70% OF OUTSTANDING BONDS Capital/Financing Update	2009-09-30	English
PHARMING’S MARKETING AUTHORISATION APPLICATION FOR RHUCIN VALIDATED BY THE EUROPEAN MEDICINES AGENCY (EMEA) Regulatory Filings	2009-09-24	English
DNAGE initiates observational study in children suffering from cockayne syndrome Regulatory Filings	2009-09-22	English
Pharming announces offer to holders of convertible bonds with financial support of current shareholders Capital/Financing Update	2009-09-21	English
Pharming to present at UBS Global Life Sciences Conference Regulatory Filings	2009-09-18	English
PHARMING PROVIDES UPDATE ON OUTSTANDING NUMBER OF SHARES Declaration of Voting Results & Voting Rights Announcements	2009-09-11	English
PHARMING SUBMITS MARKETING AUTHORISATION APPLICATION FOR RHUCIN® TO THE EMEA Regulatory Filings	2009-09-03	English
Pharming gives update on outstanding number of shares Share Issue/Capital Change	2009-08-28	English
FDA approves Investigational New Drug application for Prodarsan® in Cockayne Syndrome patients Regulatory Filings	2009-08-14	English
Pharming announces financial results first half year 2009 Interim / Quarterly Report H1 2009	2009-07-17	English
Pharming provides update on outstanding number of shares Share Issue/Capital Change	2009-07-14	English
Pharming gives update on outstanding number of shares Share Issue/Capital Change	2009-06-30	English
Pharming gives update on equity financing with YA Global Capital/Financing Update	2009-06-23	English
Pharming receives government grant to develop human lactoferrin for inflammatory bowel diseases Regulatory Filings	2009-06-18	English
Pharming announces Euro 9 million debt reduction and continued equity financing with YA Global Capital/Financing Update	2009-06-17	English
Pharming provides update on number of outstanding shares Share Issue/Capital Change	2009-06-09	English
PHARMING RECEIVES AGREEMENT ON PAEDIATRIC INVESTIGATION PLAN FOR RHUCIN® FROM THE EMEA PAEDIATRIC COMMITTEE Regulatory Filings	2009-06-04	English
Pharming to present at UBS Global Specialty Pharmaceutical Conference 2009 Investor Presentation	2009-06-03	English
Interim analysis confirms immunosafety of Rhucin® Regulatory Filings	2009-06-01	English
Prodarsan® granted Orphan Drug designation from FDA Regulatory Filings	2009-04-27	English
Pharming announces first quarter 2009 financial results Interim / Quarterly Report Q1 2009	2009-04-17	English
PHARMING ANNUAL SHAREHOLDER’S MEETING AGM Information	2009-04-16	English
Pharming secures € 20 million long term Standy Equity Agreement with Yorkville Advisors Capital/Financing Update	2009-04-15	English
Pharming proposes new members for Supervisory Board Board/Management Information	2009-03-31	English
Pharming confirms Rhucin European MAA filing timeline Regulatory Filings	2009-03-31	English
Pharming shareholders meeting to be held on 15 April 2009 Report Publication Announcement	2009-03-26	English
Pharming announces annual results 2008 Earnings Release FY 2008	2009-02-13	English
PHARMING PROVIDES BUSINESS UPDATE Management Reports	2009-01-19	English
Pharming announces debt reduction of EUR 5 million Capital/Financing Update	2009-01-19	English

Filings by year

2026 29 filings
2025 60 filings
2024 60 filings
2023 64 filings
2022 56 filings
2021 48 filings
2020 44 filings
2019 17 filings
2018 18 filings
2017 22 filings
2016 25 filings
2015 21 filings
2014 19 filings
2013 26 filings
2012 59 filings
2011 34 filings
2010 52 filings
2009 40 filings
2008 29 filings
2007 44 filings
2006 23 filings
2005 6 filings